Virtual fragment linking: An approach to identify potent binders from low affinity fragment hits

被引:29
作者
Crisman, Thomas J. [1 ]
Bender, Andreas [1 ]
Milik, Mariusz [1 ]
Jenkins, Jeremy L. [1 ]
Scheiber, Josef [1 ]
Sukuru, Sai Chetan K. [1 ]
Fejzo, Jasna [1 ]
Hommel, Ulrich [2 ]
Davies, John W. [1 ]
Glick, Meir [1 ]
机构
[1] Novartis Inst BioMed Res Inc, Ctr Prote Chem, Cambridge, MA 02139 USA
[2] Novartis Pharma AG, Ctr Prote Chem, CH-4002 Basel, Switzerland
关键词
D O I
10.1021/jm701314u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this work we explore the possibilities of using fragment-based screening data to prioritize compounds from a full HTS library, a method we call virtual fragment linking (VFL). The ability of VFL to identify compounds of nanomolar potency based on micromolar fragment binding data was tested on 75 target classes from the WOMBAT database and succeeded in 57 cases. Further, the method was demonstrated for seven drug targets from in-house screening programs that performed both FBS of 8800 fragments and screens of the full library. VFL captured between 28% and 67% of the hits (IC50 < 10 mu M) in the top 5% of the ranked library for four of the targets (enrichment between 5-fold and 13-fold). Our findings lead us to conclude that proper coverage of chemical space by the fragment library is crucial for the VFL methodology to be successful in prioritizing HTS libraries from fragment-based screening data.
引用
收藏
页码:2481 / 2491
页数:11
相关论文
共 33 条
[1]  
*ACC, SCITEGIC PIP PIL VER
[2]   Similarity searching of chemical databases using atom environment descriptors (MOLPRINT 2D): Evaluation of performance [J].
Bender, A ;
Mussa, HY ;
Glen, RC ;
Reiling, S .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (05) :1708-1718
[3]   Molecular similarity: a key technique in molecular informatics [J].
Bender, A ;
Glen, RC .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (22) :3204-3218
[4]  
Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.3.CO
[5]  
2-D
[6]   Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development [J].
Bruno, Robert D. ;
Njar, Vincent C. O. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (15) :5047-5060
[7]   New technologies for high-throughput screening [J].
Burbaum, JJ ;
Sigal, NH .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (01) :72-78
[8]   2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution [J].
Connolly, S ;
Aberg, A ;
Arvai, A ;
Beaton, HG ;
Cheshire, DR ;
Cook, AR ;
Cooper, S ;
Cox, D ;
Hamley, P ;
Mallinder, P ;
Millichip, I ;
Nicholls, DJ ;
Rosenfeld, RJ ;
St-Gallay, SA ;
Tainer, J ;
Tinker, AC ;
Wallace, AV .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (12) :3320-3323
[9]   Fragment-based drug discovery [J].
Erlanson, DA ;
McDowell, RS ;
O'Brien, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (14) :3463-3482
[10]   Virtual exploration of the small-molecule chemical universe below 160 daltons [J].
Fink, T ;
Bruggesser, H ;
Reymond, JL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (10) :1504-1508